HYPERTENTION AND RHEMATHOID ARTITIS - Nursing Case Study

Pathophysiology

Hypertension:

• Primary mechanism: Increased systemic vascular resistance due to endothelial dysfunction and overactivation of the renin-angiotensin-aldosterone system (RAAS), leading to persistent vasoconstriction and elevated blood pressure.

• Secondary mechanism: Altered sodium handling by the kidneys, resulting in increased blood volume and pressure.

• Key complication: Chronic hypertension can cause target organ damage, such as hypertensive nephropathy, accelerating renal failure.

Rheumatoid Arthritis:

• Primary mechanism: Autoimmune-mediated synovial inflammation driven by aberrant T-cell activation and cytokine release, particularly tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), leading to joint inflammation and destruction.

• Secondary mechanism: Formation of pannus tissue that invades and erodes cartilage and bone, causing joint deformities.

• Key complication: Extra-articular manifestations, including rheumatoid vasculitis, which can cause severe sys

Patient Profile

Demographics:

68-year-old female, retired school teacher

History:

• Key past medical history: Chronic hypertension for 15 years, rheumatoid arthritis for 10 years, type 2 diabetes mellitus, history of myocardial infarction 3 years ago

• Current medications: Lisinopril, Methotrexate, Metformin, Prednisone, Atenolol, Ibuprofen as needed

• Allergies: Penicillin, shellfish

Current Presentation:

• Chief complaint: Severe joint pain and difficulty breathing

• Key symptoms: Persistent headache, swelling and stiffness in multiple joints, shortness of breath, chest pain, fatigue

• Vital signs: Blood pressure 190/110 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 38.2°C (100.8°F), oxygen saturation 88% on room air

Section 1

Following the initial presentation, the medical team conducted a comprehensive assessment of the patient, which revealed significant clinical findings. The physical examination showed pronounced swelling in the patient's hands, wrists, and knees, consistent with severe rheumatoid arthritis flare. Notably, there was increased synovial thickening and warmth in these areas. Auscultation of the lungs revealed diminished breath sounds at the bases, with fine crackles, suggesting possible pulmonary involvement. Given her low oxygen saturation and difficulty breathing, an arterial blood gas analysis was conducted, revealing a pH of 7.32, pCO2 of 48 mmHg, and HCO3- of 22 mEq/L, indicative of respiratory acidosis with partial metabolic compensation.

Laboratory results further complicated the clinical picture. The patient's complete blood count showed leukocytosis with a white blood cell count of 15,000/µL, raising suspicion for an infectious process, potentially pneumonia, exacerbated by her immunosuppressive therapy. Additionally, her serum creatinine level was elevated at 2.1 mg/dL, suggesting deteriorating renal function, possibly due to hypertensive nephropathy or NSAID use. Her C-reactive protein and erythrocyte sedimentation rate were markedly elevated, confirming active systemic inflammation. Blood cultures were drawn, and a chest X-ray was ordered to assess for potential pneumonia or other pulmonary complications.

The medical team is now faced with multiple critical concerns requiring advanced clinical judgment. They must prioritize stabilizing the patient's respiratory status, managing her hypertension to prevent further renal damage, and addressing the potential infection while considering her immunosuppressed state. The interplay of these conditions necessitates a careful balance between aggressive treatment and monitoring for adverse effects. The patient's evolving condition calls for immediate interventions, including potential oxygen therapy, adjustments in her medication regimen, and possible initiation of antibiotics pending culture results, all while preparing for the possibility of further complications such as acute renal failure or sepsis.

Section 2

Change in Patient Status:

The patient's condition began to deteriorate rapidly, highlighting the complexity and urgency of her clinical status. Despite the initiation of supplemental oxygen therapy, her oxygen saturation remained critically low at 85%, necessitating the escalation to a high-flow nasal cannula. Her respiratory rate increased to 30 breaths per minute, indicating distress, and her blood pressure surged to 180/110 mmHg, exacerbating concerns about hypertensive crises. In response to these alarming changes, the medical team initiated intravenous antihypertensive therapy with labetalol to gain better control over her blood pressure and prevent further renal compromise.

Concurrently, the patient's renal function continued to worsen, with serum creatinine spiking to 2.8 mg/dL. This significant change raised the suspicion of acute kidney injury, possibly due to a combination of uncontrolled hypertension and the nephrotoxic effects of NSAIDs. Additionally, the patient's urine output decreased to less than 400 mL over the last 24 hours, confirming oliguria. The nephrology team was consulted urgently to assess the need for renal replacement therapy and to adjust her medication regimen, particularly the consideration of stopping or switching NSAIDs to less nephrotoxic alternatives.

Amid these developments, the patient's mental status began to fluctuate, with episodes of confusion and disorientation. A mini-mental status examination revealed a decline in cognitive function, possibly secondary to hypoxemia or uremic encephalopathy. This neurocognitive decline added another layer of complexity to her management, prompting the team to monitor her neurological status meticulously while preparing for potential interventions such as dialysis. The focus remained on stabilizing her rapidly evolving condition, optimizing her oxygenation, and carefully balancing her fluid and electrolyte status to mitigate further complications.

Section 3

As the medical team continued to stabilize the patient, new diagnostic results provided further insight into her deteriorating condition. A comprehensive metabolic panel revealed a worsening electrolyte imbalance, with potassium levels climbing to 5.8 mmol/L and sodium dropping to 130 mmol/L, reflecting potential hyperkalemia and hyponatremia, respectively. These imbalances heightened the risk of cardiac arrhythmias, necessitating immediate intervention to prevent life-threatening complications. The team promptly administered calcium gluconate to stabilize cardiac membranes and initiated a regimen of insulin and dextrose to drive potassium back into the cells.

Simultaneously, an arterial blood gas analysis indicated severe respiratory acidosis with a pH of 7.25 and elevated carbon dioxide levels at 55 mmHg, suggesting significant respiratory compromise. This finding aligned with her increased work of breathing and the need for continued respiratory support. The decision was made to transition the patient to non-invasive positive pressure ventilation to improve alveolar ventilation and address the acidosis. This adjustment aimed to enhance carbon dioxide clearance and subsequently improve her mental status, which had been adversely affected by her hypoxemic and hypercapnic state.

In light of these developments, the interdisciplinary team engaged in a thorough discussion to reassess the patient's treatment plan. The primary focus was on optimizing her hemodynamic stability while preventing further renal and neurologic sequelae. A decision was reached to initiate continuous renal replacement therapy (CRRT) in consultation with nephrology, providing a more controlled approach to managing her fluid overload and metabolic derangements. This intervention was anticipated to aid in correcting electrolyte imbalances and alleviate her uremic symptoms, thereby supporting her fragile physiological state as she continued to receive comprehensive care.

Section 4

As the team monitored the patient’s response to the interventions, a series of new complications emerged, necessitating further critical analysis and adjustments to the treatment strategy. Despite the initiation of continuous renal replacement therapy, the patient developed signs of worsening systemic inflammation. Her temperature spiked to 38.9°C, and her white blood cell count surged to 18,000/mm³, indicating a potential infectious process or exacerbation of her underlying rheumatologic condition. Given her history of rheumatoid arthritis, there was concern for an acute flare or secondary infection, possibly precipitated by her immunocompromised state. Blood cultures were promptly obtained, and broad-spectrum antibiotics were initiated to cover potential bacterial pathogens, while rheumatology was consulted to evaluate the need for adjustments in her immunosuppressive therapy.

Concurrently, the patient’s cardiovascular status became increasingly unstable. Her blood pressure dropped to 85/50 mmHg, and her heart rate rose to 120 bpm. These changes suggested a possible progression to septic shock or an adverse cardiovascular event linked to her electrolyte imbalances and underlying hypertension. The decision was made to cautiously administer intravenous fluids while closely monitoring for signs of fluid overload, given her renal impairment. Additionally, vasopressor support with norepinephrine was initiated to maintain adequate perfusion and prevent further end-organ damage. An echocardiogram was ordered to assess cardiac function and rule out potential myocarditis or other structural heart changes exacerbated by her systemic condition.

In this critical phase, the interdisciplinary team faced the challenge of balancing the aggressive management of her acute complications with the need to mitigate long-term risks associated with her chronic conditions. The complexity of her case underscored the necessity for continuous reassessment and collaboration across specialties, as the team worked to stabilize her hemodynamics, control the inflammatory response, and support organ function through tailored interventions. This dynamic situation set the stage for further exploration of her underlying pathology and refinement of her comprehensive care plan.

Section 5

As the interdisciplinary team continued to monitor the patient, new diagnostic results provided crucial insights into her evolving condition. The echocardiogram revealed mild left ventricular dysfunction, raising concerns about the potential impact of systemic inflammation on cardiac performance. Additionally, the blood cultures returned positive for Staphylococcus aureus, confirming a bloodstream infection that likely compounded her cardiovascular instability. This finding necessitated a swift adjustment in her antibiotic regimen to specifically target the identified pathogen, with the infectious disease specialist recommending the addition of vancomycin to her treatment protocol.

Further complicating the clinical picture, the patient’s laboratory results indicated a significant drop in hemoglobin to 8.5 g/dL, suggesting potential gastrointestinal bleeding or bone marrow suppression secondary to her immunosuppressive therapy. To address this, a fecal occult blood test was ordered to evaluate for gastrointestinal blood loss, and a hematology consult was sought to assess the need for a blood transfusion and potential modifications to her immunosuppressive regimen. Meanwhile, her renal function continued to deteriorate, with creatinine levels rising to 3.2 mg/dL despite ongoing renal replacement therapy, prompting nephrology to reevaluate her fluid and electrolyte management strategy.

These developments underscored the complexity of managing a patient with comorbid conditions in a critically ill state. The team faced the challenge of integrating these new findings into a cohesive treatment plan, balancing the need for aggressive infection control with the careful management of her cardiovascular and renal systems. As they adjusted her care plan, the team remained vigilant for further complications, recognizing the importance of ongoing interdisciplinary collaboration and continuous reassessment to navigate the intricacies of her case effectively.